SUNDARAM NSE filing

Sundaram Multi Pap Q4 FY26 Results: Revenue ₹45.5 Cr, Net Profit ₹1.17 Cr

The RealCase readMedium impact Positive

Sundaram Multi Pap reported Q4 FY26 revenue of ₹45.52 crore and a net profit of ₹1.17 crore. For the full year FY26, revenue was ₹139.20 crore and net profit was ₹3.18 crore. The company withdrew its proposed preferential issue of 7.04 crore equity shares.

Why it matters

The financial results show a positive turnaround, but the withdrawal of the preferential issue might indicate potential challenges or a change in strategic direction that could impact future growth.

The market read

The company reported improved financial performance with increased revenue and a shift from loss to profit for both the quarter and the full financial year.

Sundaram Multi Pap Limited announced its audited standalone financial results for the quarter and financial year ended March 31, 2026.

For the fourth quarter of FY26, the company reported a total income from operations of ₹4,551.57 lakh (₹45.52 crore), a significant increase from ₹4,160.88 lakh (₹41.61 crore) in the same quarter of the previous year. The net profit after tax for the quarter stood at ₹117.34 lakh (₹1.17 crore), a notable improvement from a loss of ₹85.26 lakh (₹0.85 crore) in the corresponding quarter of FY25.

For the full financial year ended March 31, 2026, the total income from operations was ₹13,920.38 lakh (₹139.20 crore), up from ₹12,940.50 lakh (₹129.41 crore) in FY25. The net profit after tax for the full year was ₹317.95 lakh (₹3.18 crore), compared to a loss of ₹512.07 lakh (₹5.12 crore) in the previous financial year.

The company also disclosed that the Board of Directors, on March 5, 2026, resolved to withdraw the proposed preferential issue of 7,04,00,000 equity shares. This decision followed a communication from Sundaram Land and Assets Private Limited (SLAPL) on February 27, 2026, expressing its decision not to proceed with the proposed share swap transaction.

Filing to action

What to do with a filing like this

Sundaram Multi Pap Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sundaram Multi Pap Limited. Read the original for the full detail.

View original filing